መነሻ › አኩት ማይሎይድ ሊውኬሚያ › ካንሳስ › Kansas City
በKansas City፣ KS ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ 12 ጥናቶች በKansas City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Kansas Cancer Center, Kansas City
Ivosidenib as Post-HSCT Maintenance for AML
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Kansas University Medical Center, Kansas City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 ማይል ርቀት
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Kansas Cancer Center, Kansas City
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Kansas Cancer Center, Kansas City
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Kansas Cancer Center, Kansas City
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Kansas Cancer Center, Kansas City
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- US-Kansas City KS-KUMC, Kansas City
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Kansas Cancer Center, Kansas City
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of Kansas Cancer Center, Kansas City
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Kansas Medical Center Research Institute, Inc., Kansas City
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
ተሳታዮችን በመፈለግ ላይደረጃ 1
- KU Cancer Center, Kansas City
በሌሎች ከተሞች ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ጥናቶች
- Houston, TX85 ጥናቶች
- New York City, NY51 ጥናቶች
- Boston, MA44 ጥናቶች
- Seattle, WA41 ጥናቶች
- Baldwin Park, CA40 ጥናቶች
- Columbus, OH35 ጥናቶች
- Philadelphia, PA34 ጥናቶች
- Durham, NC33 ጥናቶች
- Atlanta, GA31 ጥናቶች
- Tampa, FL29 ጥናቶች
- Chicago, IL26 ጥናቶች
- Portland, OR25 ጥናቶች
በKansas City ውስጥ ያሉ ሌሎች ጥናቶች
- የልብና የደም ዝውውር ሕመም14 ጥናቶች
- የልብ ድካም13 ጥናቶች
- ከባድ ሰውነት13 ጥናቶች
- የሳንባ መካከለኛ ሕዋስ በሽታዎች13 ጥናቶች
- ሲስቲክ ፋይብሮሲስ13 ጥናቶች
- የጡንቻ ካንሰር12 ጥናቶች
- የሽንት ፊኛ ካንሰር12 ጥናቶች
- የፕሮስቴት ካንሰር12 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር11 ጥናቶች
- የሳንባ ካንሰር11 ጥናቶች
- ሲ.ኦ.ፒ.ዲ9 ጥናቶች
- አስማ8 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።